NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

My conclusion from this exchange:
From this conversation, I conclude that the DCVax-L application has never been classified as a backlog case, nor has it been delayed due to major objections or assessment stoppages. The MAA has remained in continuous assessment throughout, without falling into the category of stuck or problematic applications that required intervention by the Commission on Human Medicines (CHM). This supports the positive view that the application is proceeding through the normal (albeit lengthy) assessment and inspection phases, and that it was never among the applications with major issues precluding approval.

exactly and a second RFI sent to NWBO at the end of March is within that margin. Just because it doesn't fit peoples perspective thrown out by Tunnelvision doesn't mean that DCVAXL application is facing problems its not. It was Tunnelvision that was applauded and hailed here, I was always skeptical about his timeline, whereas there is a different, longer timeline for the DCVAXL application with two RFI's. NWBO is now in the second clock off time